Clinical Trial Update: A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a basal-bolus insulin regimen (insulin degludec/aspart once daily plus meal-time insulin aspart) versus detemir with meal-time insulin …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin aspart (insulin aspart)
• Insulin detemir (insulin detemir)
• insulin degludec/insulin aspart (insulin degludec/insulin aspart)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED | Results posted: 2015-11-17